Oral Cancer Conference 2019
Currently, oral and oropharyngeal squamous cell carcinoma (OSCC) is the 6th most common cancer world-wide, and is associated with poor survival rates. This interactive, case-based symposium is designed to update medical and dental colleagues on the latest advances in the diagnosis, treatment, and postsurgical management of oral cavity and head and neck cancer.
The poor survival rate of OSCC is primarily attributed to delays in diagnosis, and therefore, advanced staging at onset. It is imperative to diagnosis lesions early, although early detection strategies, while emerging, are not yet part of the standard of care. Community clinicians, including dentists and otolaryngologists, are on the front line for the early detection and surveillance of this disease, as well as in managing the chosen medical treatment and its impact for their patients.
Oral Malignant and Potentially Malignant LesionsBilly Ballard, DDS, MD, and M. Abraham Kuriakose, MD, put into perspective the essence of oral cancer. At the current rate 53,000 new cases of oral cancer will be diagnosed this year and of that 11,000 of those patients will die from that ...
Dental Care of Oral Cancer PatientsAs part of the Oral Cancer Conference 2019, Heidi Crow, DDS, shares dental concerns for patients with oral cancer. This lecture covers pre-treatment, peri-treatment, and post treatment.
Interim Clinical Chief, Dentistry and Maxillofacial Prosthetics Department
Radiation and Chemotherapy MucositisAnurag Singh, MD, has one important message. When you see one of his patients with Radiation Mucositis, “Do not prescribe them anything.” This lecture will cover the incidence/etiology, supportive care, and lastly a few new directions in treatment.
Director of Radiation Research, Department of Radiation Medicine
Co-Leader, Cell Stress and Biophysical Therapies Program
Associate Dean of Graduate Medical Education, Research
Osteoradionecrosis and Medication-Related OsteonecrosisKeith Kirkwood, DDS, PhD, will explain how to understand the similarities and differences between osteoradionecrosis of the jaw and medication related osteonecrosis of the jaw. Lastly, how to summarize the ration-induced fibroatrophic ...
Mandible and Maxilla ReconstructionCan Ozturk, MD, discusses common indications for mandibular reconstruction as well as reconstruction goals.
Function and Frailty Status Pre- and Post- Treatment for Oral CancerAndrew Ray, PhD, PT, takes a look at the functionality and frailty of patients who are malnourished, have sarcopenia, or cachexia.